Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Hillary Clinton opposes the Trans-Pacific Partnership, which she once supported

In a major blow to President Obama’s trade agenda, Democratic presidential frontrunner Hillary Clinton has come out against the Trans-Pacific Partnership. In an interview with PBS’s Judy Woodruff, Clinton stressed that she hadn’t seen the full agreement. However, she said, “As of today, I am not in favor of what I have learned about it. I don’t believe it’s going to meet the high bar I have set.”

Clinton explained her skepticism by mentioning two of the most common objections to the deal among left-leaning critics: that it’s too favorable to pharmaceutical companies, and that it doesn’t include language prohibiting other countries from manipulating their currencies to gain a trade advantage.

The lack of currency manipulation language is a key concern of the labor movement, whose support could be crucial in next year’s Democratic primary elections. Meanwhile, public health groups have raised concerns about language in the TPP that could raise the cost of medicines worldwide.

Obama faces a tough vote on the trade deal next year, and Clinton’s comments won’t help. They will give political cover to wavering congressional Democrats who want to help Obama but are also feeling grassroots pressure from labor unions and other liberal groups.

Clinton’s comments also represent something of a flip-flop. During her time as Obama’s secretary of state, from 2009 to 2013, Clinton repeatedly promoted the trade deal. While the final text is different from versions being considered when she was in office, neither of the concerns she’s raising today — about benefits to pharmaceutical companies and the lack of language on currency manipulation — have changed since then.

See More:

More in Politics

Podcasts
The Supreme Court abortion pills case, explainedThe Supreme Court abortion pills case, explained
Podcast
Podcasts

How Louisiana brought mifepristone back to SCOTUS.

By Peter Balonon-Rosen and Sean Rameswaram
Politics
Trump’s China policy is nearly the exact opposite of what everyone expectedTrump’s China policy is nearly the exact opposite of what everyone expected
Politics

As Trump heads to China, attention and resources are being shifted from Asia to yet another war in the Middle East.

By Joshua Keating
Politics
Are far-right politics just the new normal?Are far-right politics just the new normal?
Politics

Liberals are preparing for a longer war with right-wing populists than they once expected.

By Zack Beauchamp
The Logoff
Flavored vapes doomed Trump’s FDA headFlavored vapes doomed Trump’s FDA head
The Logoff

Why Marty Makary is out at the FDA, briefly explained.

By Cameron Peters
Politics
Virginia Democrats’ irresponsible new plan to save their gerrymanderVirginia Democrats’ irresponsible new plan to save their gerrymander
Politics

Democrats just handed the Supreme Court’s Republicans a loaded weapon.

By Ian Millhiser
The Logoff
Can Trump lower gas prices?Can Trump lower gas prices?
The Logoff

What suspending the gas tax would mean for you, briefly explained.

By Cameron Peters